{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-003270","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2026-05-12T11:30:18+00:00","discovered_at":"2026-05-12T11:35:00.340358+00:00","generated_at":"2026-05-12T11:39:30.313723+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Harvard Bioscience Q1 revenue $20.8M, gross margin 59%; reaffirms FY guidance","bullets":["Revenue $20.8M (down 5% YoY from $21.8M); net loss $(3.4)M vs $(50.3)M including $48M impairment.","Gross margin 59% (vs 56% prior year); driven by higher-margin NPI mix (MeshMEA, BTX, SoHo).","Adjusted EBITDA $0.8M flat YoY; cash used in ops $(0.7)M vs $3.0M in Q1 2025.","Reaffirms full-year 2026 guidance; manufacturing consolidation on track for efficiencies."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003270","json":"https://secwatch.observer/filing/0001171843-26-003270.json","markdown":"https://secwatch.observer/filing/0001171843-26-003270.md","text":"https://secwatch.observer/filing/0001171843-26-003270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326003270/0001171843-26-003270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326003270/f8k_050826.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T11:39:30.313723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f9da319d65f43196d975d83b1becd35c272898a9","claim":"HARVARD BIOSCIENCE INC reported the first quarter ended March 31, 2026 results: revenue $20.8 million, net income $(3.4) million. Guidance reaffirmed.","evidence_excerpt":"margin NPI sales growth driving bottom line growth in the second half of the year.” First Quarter 2026 Results For the first quarter of 2026, the Company reported revenues of $20.8 million compared to $21.8 million in the first quarter of 2025. Gross margin for the first quarter of 2026 was 59%, compared to 56% in the first quarter of 2025. Net loss for the first","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326003270/0001171843-26-003270-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$20.8 million"},{"label":"Net income","value":"$(3.4) million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}